How should I transition an intravenous nitroglycerin infusion to oral nitroglycerin in a patient with acute kidney injury who cannot receive angiotensin‑converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs)?

Transitioning IV Nitroglycerin to Oral Nitrates in AKI Without ACEi/ARB

When transitioning from IV nitroglycerin to oral formulations in a patient with AKI who cannot receive ACEi/ARB, apply nitroglycerin ointment 2% at the equivalent dose and discontinue the IV infusion 30 minutes later, while maintaining careful blood pressure monitoring to avoid hypotension—which is particularly critical in renal dysfunction. 1

Transition Strategy

Recommended Method

The most efficient and clinically validated approach is the "apply-and-stop" method 2:

• Apply nitroglycerin ointment 2% at the calculated dose
• Wait 30 minutes, then discontinue IV nitroglycerin
• This method reduces ICU time by approximately 23 minutes and nursing time by 45 minutes compared to gradual weaning, with no difference in clinical outcomes including recurrent angina 2

Dose Conversion

Calculate the oral/topical dose based on IV infusion rate:

• For sublingual nitroglycerin: 0.3-0.6 mg every 5 minutes as needed (up to 3 doses) 3, 4, 5
• For nitroglycerin ointment 2%: Apply topically every 12 hours with a nitrate-free interval to prevent tolerance 1
• For isosorbide dinitrate: 5-80 mg orally 2-3 times daily 1
• For isosorbide mononitrate: 20 mg twice daily or 60-240 mg once daily (extended-release) 1

Critical Considerations in AKI

Blood Pressure Management

Hypotension must be avoided, especially in patients with renal dysfunction 6:

• Maintain systolic blood pressure ≥90 mm Hg 7, 3, 4
• Avoid nitrates if SBP drops ≥30 mm Hg below baseline 7
• Monitor blood pressure frequently during transition—an arterial line is not routinely required but facilitates titration in borderline pressures 6

Why This Matters in AKI

Patients with AKI are particularly vulnerable to hypotension because:

• Reduced renal perfusion can worsen kidney injury
• Volume status is often difficult to assess
• Neurohormonal activation may already be present 6

Alternative Vasodilator Options (Since ACEi/ARB Contraindicated)

Beta-Blockers

Oral beta-blockers should be initiated within 24 hours if not already on therapy 8, 7:

• Start with low doses after hemodynamic stabilization 8
• More powerful salutary effects than nitrates for mortality reduction 7
• Can be continued safely even during acute decompensation 9

Hydralazine

While not explicitly mentioned in the guidelines for this specific scenario, hydralazine is a reasonable alternative vasodilator in patients who cannot receive ACEi/ARB and need afterload reduction, particularly if heart failure is present.

Tolerance Prevention

Tachyphylaxis develops after 24-48 hours of continuous nitrate therapy 6, 1:

• Implement a nitrate-free interval of 10-14 hours daily
• For transdermal patches: Apply for 12 hours, remove for 12 hours 1
• For oral formulations: Dose asymmetrically (e.g., 8 AM and 2 PM, not 8 AM and 8 PM)
• If breakthrough symptoms occur during nitrate-free interval, consider adding a beta-blocker or calcium channel blocker rather than continuous nitrate coverage

Monitoring Parameters

During Transition (First 24-48 Hours)

• Blood pressure: Every 15-30 minutes initially, then hourly once stable
• Heart rate: Continuous telemetry
• Symptoms: Chest pain, dyspnea, headache
• Renal function: Daily creatinine and urine output
• Volume status: Daily weights, intake/output

Common Pitfalls to Avoid

1. Abrupt discontinuation of IV nitroglycerin without oral coverage can cause rebound ischemia 1
2. Excessive dose reduction out of fear of hypotension may lead to inadequate symptom control
3. Ignoring the nitrate-free interval leads to tolerance and treatment failure
4. Combining multiple vasodilators (e.g., nesiritide + nitroglycerin) is not recommended 6

Special Considerations

If Blood Pressure is Borderline (SBP 90-110 mm Hg)

• Use nitrates with extreme caution 6
• Consider starting with lower doses
• Ensure adequate volume status before transition
• Have IV fluids readily available

If Ongoing Ischemia Despite Oral Nitrates

• Morphine sulfate 2-4 mg IV every 5-15 minutes (up to 10 mg) for refractory pain 3, 4
• Note: Morphine may delay absorption of oral P2Y12 inhibitors if PCI is planned 3, 4
• Consider fentanyl 25-50 mcg IV as alternative 3, 4

Regarding ACEi/ARB in AKI

While your patient cannot currently receive ACEi/ARB, recent evidence suggests that continuation or initiation of ACEi/ARB after AKI recovery may improve long-term mortality 10, 11, 12, though with increased risk of hypotension and hyperkalemia 12. Once renal function stabilizes, reassess the risk-benefit ratio for ACEi/ARB initiation, particularly if hypertension or heart failure is present.